Option Care Health reports Q2 revenue up 1.9%, raises full-year guidance, repurchases $150M

Filed July 29, 2026 · Period ending July 29, 2026 · ~1 min read

Key Changes

• high

  Repurchased $150M of shares in Q2 2026, reducing weighted average diluted shares outstanding from 164.1M to 153.5M year-over-year.

  Exhibit 99.1 view on EDGAR →
• high

  Q2 2026 net revenue $1,442M (up 1.9% YoY); GAAP diluted EPS $0.35 (up 12.9%); adjusted diluted EPS $0.45 (up 9.8%); adjusted EBITDA $117.5M (up 3.0%).

  Exhibit 99.1 view on EDGAR →
• high

  Raised full-year 2026 guidance: net revenue $5.675B–$5.775B, adjusted diluted EPS $1.85–$1.92, adjusted EBITDA $480M–$495M, operating cash flow at least $320M.

  Exhibit 99.1 view on EDGAR →